Bonit Capital is a Swedish family-owned investment company.
We invest across sectors and asset classes, including social investments and outcome models.
We partner with entrepreneurs and managers for the long-term focusing on lasting value creation.
We invest in ambitious founders within the life science sector. We take an active ownership approach by providing capital, industry expertise and access to an international network. Our focus areas are digital health, medical technology and diagnostics.
We invest in entrepreneurial teams with deep sector expertise and unique market access, primarily in the lower to mid-market buyout segment, with the aim to produce superior returns and meaningful portfolio diversification.
Our strategy is to obtain a broad market exposure through mainly external mandates, and to seek superior returns in individual shares primarily in life science. Among Bonit's main holdings are the world-leading medtech company Elekta AB, founded by Laurent Leksell.
Leksell Social Ventures (LSV) is the first impact investor in Sweden with a focus on outcome models and direct investments in the areas of mental health, education and social integration. Striving for systemic change, LSV contributes to social innovation and societal development by giving social entrepreneurs and social ideas the necessary prerequisites to develop and progress – through financing, idea development and networking with private, public and nonprofit actors.
Leksell Social Ventures portfolio company Mindmore is the winner of Di Digital's Health Tech Pitch Day 2020. Mindmore's digital platform makes it easier to test patients against dementia and depression. Mindmore is now in the starting blocks to take the next step in the fight for better brain health. Congratulations Sara and team!
Read Full ArticleHow does Bonit Capital think about its investments in digital health, diagnostics and medical technology? Life Science Sweden has interviewed Richard Leksell, partner and responsible for direct investments at Bonit Capital.
Read Full ArticleSweden's largest marketplace for search and booking healthcare is making its first capital raising led by Bonit Capital. "The healthcare sector is facing major challenges. We must use digital tools and e-health to support the Swedish healthcare system. Vården.se is a key player in this transformation and we look forward to supporting the company to become a leading player in search and booking of care in Sweden and internationally, says Richard Leksell, partner at Bonit Capital.
Read Full ArticleHealth Integrator is an important investment for us as the company offers both the public sector, corporate health, and the individual a way to finance and customize preventive health. A measurable solution to a prioritized social problem and a system change in how society thinks about health, says Hugo Mörse, CEO of Leksell Social Ventures.
Read Full ArticleThe proceeds from the Directed Issue are intended to finance the Company’s investments in an accelerated commercialization start for IMMray™ PanCan-d. In addition to strong support from existing and new local investors, the Company also attracted sizeable amounts from international investors who participated thus further broadening its shareholder base.
Read Full ArticleUnder the terms of the agreement, Affibody will receive a $10 million upfront payment and is eligible to receive up to $215.5 million in additional regulatory and sales milestones, plus royalties on sales in Inmagene’s commercialization territory.
Read Full ArticleWith surging demand for mental health counselling, Meru Health has raised $8.1 million to offer virtual therapy. Venture capital firm Foundry Group led the funding. Workplace productivity firm Slack and Bold Capital also joined the funding round.
Read Full ArticleLeksell Social Ventures och Sana Labs samarbetar för att lansera en ny SFI-utbildning baserad på AI-teknik. Leksell Social Ventures har länge engagerat sig i integrationsfrågor och en frågeställning som investeringsbolaget haft är hur de kan bidra till att förbättra det svenska SFI-systemet.
Read Full ArticleSysmex aims to help commercialize a rapid drug susceptibility test that Astrego is developing for urinary tract infections. Urinary tract infections are infectious diseases with a high rate of incidence and are said to affect 150 million people globally. With this investment, Sysmex acquired 24.99% of Astrego’s shares.
Read Full ArticleGenom att lösa sjukvårdens korta, oförutsägbara, vakanser hoppas medtech-bolaget Medpeople kunna lösa ett större problem med långa vakanser inom sjukvården. Med en app där vårdpersonal kan välja bland olika uppdrag vill bolaget hitta extern bemanning till sjukvården, utan att den ska behöva använda sig av långa konsultuppdrag.
Read Full ArticleThe new $300m fund invests in technology companies that are benefiting from and supporting the global transition to lower carbon economies and that have a fundamental Climate Positive™ impact. By targeting both financial returns and impact, the firm aims to attract more capital into this rapidly growing sector and to contribute to the critical need for investment into near-term climate solutions.
Read Full ArticleMedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has presented the “Medical Device Engineering Breakthrough” award in the 2019 MedTech Breakthrough Awards program to Elekta for its Elekta Unity MR-linac.
Read Full ArticleThis is a major breakthrough in the global quest for a reliable non-invasive blood test for early detection of cancer. IMMray™ PanCan-d blood-based test for early detection of pancreatic cancer now set for Q3 2020 launch.
Read Full ArticleLSV har genomfört tre nya direktinvesteringar - Sana Labs, Meru Health och Just Arrived. Utbildning, psykisk hälsa och integration fortsätter vara fokusområden för LSV.
Read Full ArticleStrålterapibolaget Elekta redovisar ett ebita-resultat på 985 miljoner kronor för det fjärde kvartalet i sitt brutna räkenskapsår.
Read Full ArticleThis morning, Finland and Palo Alto-based Meru Health, maker of a mental health platform, landed $4.2 million in seed funding. The new money comes from Freestyle Capital, Bonit Capital, Y Combinator, Lifeline Ventures and IT-Farm.
Read Full ArticleNyligen fick det svenska medicinteknikbolaget Coala Life sin hjärtmonitor FDA-godkänd. Nu tar man in 92 miljoner kronor i riskkapital och siktar på en snabbexpansion i USA.
Read Full ArticleMonterro vill ta fler svenska mjukvarubolag ut i världen. Nu har riskkapitalbolaget fyllt på en ny fond med 2,5 miljarder kronor. ”Vi tycker att det är en fördel att vara snäva”, säger grundaren Thomas Bill.
Read Full ArticleNu tar ScientificMed in 10 miljoner kronor för att snabba på utvecklingen och satsa internationellt. Bonit Capital leder rundan. Det är familjen Leksells (som även är huvudägare i medicinteknikbolaget Elekta) investmentbolag.
Read Full ArticleI Norrköping ska en privat investering minska antalet återplacerade ungdomar på HVB-hem. Sociala utfallsmodellen bygger på ett kontrakt som ”vänder uppochner på allt vi sagt om privat välfärd”, enligt det socialdemokratiska kommunalrådet, tidigare partisekreteraren Lars Stjernkvist.
Read Full Article”Hur kommer det sig att pucken hamnade där du inte vill att den ska eller borde ligga?” Den frågan ställer Elektagrundaren Larry Leksell under Di:s intervju om boken ”Strålande tider: Hur jag gjorde Elekta till ett världsföretag”.
Read Full Article
